NRIX Exercise Disclosure
Hansen Gwenn · SEC Form 4 · Filed Nov 2, 2026
Exercise
Calculated transaction value
$0
Hansen Gwenn Chief Scientific Officer
NRIX
Nurix Therapeutics
NRIX
Transaction date
Oct 30, 2026
Public filing date
Nov 2, 2026
Filing lag
Filed 3 days later
NRIX daily price context
Close on/before transaction
$26.8
Oct 30, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Restricted Stock Units on Common Stock
- Quantity / price
- 2,859 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001817160-26-000023
Filing cohort
Transactions in this filing
Showing 10 of 10
Trades
10
Issuers
1
Estimated value
$145.6K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Nurix Therapeutics, Inc. NRIX | Sale | Nov 2, 2026 | $38.91K |
| Nurix Therapeutics, Inc. NRIX | Exercise | Nov 2, 2026 | $0 |
| Nurix Therapeutics, Inc. NRIX | Exercise | Nov 2, 2026 | $2.7K |
| Nurix Therapeutics, Inc. NRIX | Exercise | Oct 30, 2026 | $0 |
| Nurix Therapeutics, Inc. NRIX | Exercise | Oct 30, 2026 | $0 |
| Nurix Therapeutics, Inc. NRIX | Exercise | Oct 30, 2026 | $0 |
| Nurix Therapeutics, Inc. NRIX | Sale | Oct 30, 2026 | $103.99K |
| Nurix Therapeutics, Inc. NRIX | Exercise | Oct 30, 2026 | $0 |
| Nurix Therapeutics, Inc. NRIX | Exercise | Oct 30, 2026 | $0 |
| Nurix Therapeutics, Inc. NRIX Current | Exercise | Oct 30, 2026 | $0 |